Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 71335-3153

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 71335-3153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4cd7b19c D80f 4c80 8795 F4c9566ab59a 01)

Chemical structure of bupropion hydrochloride showing a chlorinated phenyl ring attached to a ketone and tert-butyl group, with an HCl component indicated.*

FDA Label Image

Label (Lbl713353153)

Label for bupropion hydrochloride extended-release tablets, USP (XL) 150 mg. The label indicates a package size of 30 tablets, with Bryant Ranch Prepack as the repackager and Graviti Pharmaceuticals Pvt. Ltd. as the manufacturer. Includes storage instructions, dosage directions, warnings, and QR codes for additional prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.